Our news

  • Stroke is a major cause of death and disability across the world, with many reviews from the Cochrane Stroke Group providing evidence on the effects of treatments and rehabilitation interventions. In November 2019, the Group published their update of their review of selective serotonin reuptake inhibitors and we asked lead author, Gillian Mead...
    March 9 2020
  • In this interview with Dr. Lee Hooper we find out more about this new Cochrane review - Omega-3 fatty acids for the primary and secondary prevention of cardiovascular diseaseTell us about this Cochrane ReviewThere is a great deal of public belief in the cardiovascular benefits of omega-3 fats.  Intakes of long-chain omega-3 fats in the US are...
    March 2 2020
  • Most Cochrane Reviews seek to cover both the benefits and harms of interventions, but the complexity of the research on the adverse effects of some treatments means that a few reviews are dedicated to just the potential harms. One of these, on one of the drugs used for treating asthma was updated in September 2019, and lead author, Sadia Janjua...
    February 24 2020
  • In this interview we ask Rebecca Hodder from the National Health and Medical Research Centre Early Career Research Fellow, the University of Newcastle, Australia and Nicole Martin, Managing Editor, Cochrane Heart, University College London, London, UK to tell us more about this Living Systematic Review, which looks at increasing fruit and...
    February 20 2020
  • Depression is common after stroke yet often is not detected or inadequately treated.Review authors from Australia, Canada, Taiwan and the UK asked, "Do pharmacological treatments, non‐invasive brain stimulation, psychological treatments, or combination treatments reduce the proportion of people with depression or the extent of depressive symptoms...
    January 28 2020
  • New Cochrane Library Special Collection 20 November 2019 is the Global Initiative for Chronic Obstructive Pulmonary Disease’s World COPD day. Chronic obstructive pulmonary disease (COPD) is a chronic lung disease. The main symptoms are shortness of breath, cough, and sputum production. COPD is caused by breathing in noxious particles or gases from...
    November 19 2019
  • A report on Saturated Fats and Health by the Scientific Advisory Committee on Nutrition (SACN) has recently been published by Public Health England using evidence from the Cochrane Heart Group review, Reduction in saturated fat intake for cardiovascular disease.The report from Public Health England considers the relationship between saturated fats...
    November 6 2019
  • Cochrane Heart will be conducting priority setting exercises, to find out which questions are most important to focus on in terms of treating heart diseases and preventing cardiovascular diseases. We are undertaking priority setting so that our research concentrates on topics that are important to people, and on research that has not yet been done...
    October 31 2019
  • Asthma is a disease of the lungs, symptoms include wheezing, breathlessness, and chest tightness.Two main features of asthma are underlying inflammation and bronchoconstriction (tightening of the muscles around small tubes in the lungs). The inflammation can be treated with daily steroid inhalers. The bronchoconstriction can be treated with a...
    September 26 2019
  • One of the earliest Cochrane Reviews on high blood pressure was first published in 1998, investigating treatments for the elderly. It was substantively updated for a second time in June 2019 and we asked the lead author, Vijaya Musini, from the University of British Columbia in Vancouver Canada to tell us about the evidence.High blood pressure or...
    September 18 2019

Pages

Subscribe to Our news